| Dr Daniel Sufficool, MD | |
|
300 Saint Lukes Dr, Montgomery, AL 36117-7102 | |
| (334) 273-8877 | |
| (334) 273-9733 |
| Full Name | Dr Daniel Sufficool |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 9 Years |
| Location | 300 Saint Lukes Dr, Montgomery, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083098669 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 44753 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Medical Center South | Montgomery, AL | Hospital |
| Jackson Hospital & Clinic Inc | Montgomery, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Physician Network, P.c. | 0840337721 | 25 |
| Alabama Cancer Care, Llc | 1456477645 | 15 |
News Archive
More than 115 Americans die every day of opioid overdose. Many more survive thanks to the antidote medication, naloxone. But a study out Monday finds that just 3 in 10 patients revived by an EMT or in an emergency room received the follow-up medication known to avoid another life-threatening event.
The Universidad Politécnica de Madrid's Artificial Intelligence Group (LIA), based at the Facultad de Informática, has created a new DNA-based biological sensor that has potential applications in the field of genetic diagnostics. The basic sensor design was presented at the 2010 Conference on Unconventional Computation.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
The global economic recession of 2008-09 has been followed by a decline in fertility rates in Europe and the United States, bringing to an end the first concerted rise in fertility rates in the developed world since the 1960s, according to research published today.
› Verified 6 days ago
| Entity Name | Southeast Physician Network, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598090839 PECOS PAC ID: 0840337721 Enrollment ID: O20091026000423 |
News Archive
More than 115 Americans die every day of opioid overdose. Many more survive thanks to the antidote medication, naloxone. But a study out Monday finds that just 3 in 10 patients revived by an EMT or in an emergency room received the follow-up medication known to avoid another life-threatening event.
The Universidad Politécnica de Madrid's Artificial Intelligence Group (LIA), based at the Facultad de Informática, has created a new DNA-based biological sensor that has potential applications in the field of genetic diagnostics. The basic sensor design was presented at the 2010 Conference on Unconventional Computation.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
The global economic recession of 2008-09 has been followed by a decline in fertility rates in Europe and the United States, bringing to an end the first concerted rise in fertility rates in the developed world since the 1960s, according to research published today.
› Verified 6 days ago
| Entity Name | Alabama Cancer Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447579644 PECOS PAC ID: 1456477645 Enrollment ID: O20100924000724 |
News Archive
More than 115 Americans die every day of opioid overdose. Many more survive thanks to the antidote medication, naloxone. But a study out Monday finds that just 3 in 10 patients revived by an EMT or in an emergency room received the follow-up medication known to avoid another life-threatening event.
The Universidad Politécnica de Madrid's Artificial Intelligence Group (LIA), based at the Facultad de Informática, has created a new DNA-based biological sensor that has potential applications in the field of genetic diagnostics. The basic sensor design was presented at the 2010 Conference on Unconventional Computation.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
The global economic recession of 2008-09 has been followed by a decline in fertility rates in Europe and the United States, bringing to an end the first concerted rise in fertility rates in the developed world since the 1960s, according to research published today.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Sufficool, MD 1400 Afflink Pl Ste 101, Tuscaloosa, AL 35406-2452 Ph: (205) 366-9740 | Dr Daniel Sufficool, MD 300 Saint Lukes Dr, Montgomery, AL 36117-7102 Ph: (334) 273-8877 |
News Archive
More than 115 Americans die every day of opioid overdose. Many more survive thanks to the antidote medication, naloxone. But a study out Monday finds that just 3 in 10 patients revived by an EMT or in an emergency room received the follow-up medication known to avoid another life-threatening event.
The Universidad Politécnica de Madrid's Artificial Intelligence Group (LIA), based at the Facultad de Informática, has created a new DNA-based biological sensor that has potential applications in the field of genetic diagnostics. The basic sensor design was presented at the 2010 Conference on Unconventional Computation.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
The global economic recession of 2008-09 has been followed by a decline in fertility rates in Europe and the United States, bringing to an end the first concerted rise in fertility rates in the developed world since the 1960s, according to research published today.
› Verified 6 days ago
Dr. David C Montiel, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2055 Normandie Dr, Suite 108, Montgomery, AL 36111 Phone: 334-288-4624 Fax: 334-280-3628 | |
Dr. Jason H Dorey, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2055 Normandie Dr, 108, Montgomery, AL 36111 Phone: 334-288-4624 Fax: 334-280-3628 | |
Dr. Oscar Padilla Orille, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2055 Normandie Dr, Suite 108, Montgomery, AL 36111 Phone: 334-288-4624 Fax: 334-280-3628 | |
Dr. George H. Wakefield Iii, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1825 Park Pl, Montgomery, AL 36106 Phone: 334-293-8747 | |
Dr. Alexander C Whitley, MD PHD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4143 Carmichael Rd, Montgomery, AL 36106 Phone: 334-395-2200 Fax: 334-395-2290 | |
Dr. Byron C Machen, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2055 Normandie Dr, 108, Montgomery, AL 36111 Phone: 334-288-4624 Fax: 334-280-3628 |